 | • レポートコード：MRC309Z7189 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の体内神経調節装置の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の体内神経調節装置市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 体内神経調節装置の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 体内神経調節装置市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・金属生体材料、高分子生体材料、セラミックス生体材料 用途別セグメント ・病院、診療所、在宅医療、その他 主要な市場プレーヤー ・Medtronic PLC、BostonScientific Corporation、Cyberonics、BioControl Medical、Aleva Neurotherapeutics SA、Bioness、Uroplasty、Abbott Laboratories、St.Jude Medical、EnteroMedics、,Micron Medical Corporation、LivaNova PLC、NeuroPace、Synapse Biomedical、Soterix Medical、Accellent、Neuros Medical、Nevro Corp 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、体内神経調節装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な体内神経調節装置メーカーの企業概要、2019年～2022年までの体内神経調節装置の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な体内神経調節装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別体内神経調節装置の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの体内神経調節装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での体内神経調節装置市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および体内神経調節装置の産業チェーンを掲載しています。 ・第14、15章では、体内神経調節装置の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 体内神経調節装置の概要 - 種類別分析（2018年vs2022年vs2029年）：金属生体材料、高分子生体材料、セラミックス生体材料 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、在宅医療、その他 - 世界の体内神経調節装置市場規模・予測 - 世界の体内神経調節装置生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Medtronic PLC、BostonScientific Corporation、Cyberonics、BioControl Medical、Aleva Neurotherapeutics SA、Bioness、Uroplasty、Abbott Laboratories、St.Jude Medical、EnteroMedics、,Micron Medical Corporation、LivaNova PLC、NeuroPace、Synapse Biomedical、Soterix Medical、Accellent、Neuros Medical、Nevro Corp ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：金属生体材料、高分子生体材料、セラミックス生体材料 ・用途別分析2018年-2029年：病院、診療所、在宅医療、その他 ・体内神経調節装置の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・体内神経調節装置のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・体内神経調節装置のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・体内神経調節装置の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・体内神経調節装置の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Internal Neuromodulation Device market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Internal Neuromodulation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Internal Neuromodulation Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Internal Neuromodulation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Internal Neuromodulation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Internal Neuromodulation Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Internal Neuromodulation Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Internal Neuromodulation Device market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic PLC, BostonScientific Corporation, Cyberonics, BioControl Medical and Aleva Neurotherapeutics SA, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Internal Neuromodulation Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Metal Biomaterials
Polymer Biomaterial
Ceramic Biomaterial
Market segment by Application
Hospital
Clinic
Home Healthcare
Other
Major players covered
Medtronic PLC
BostonScientific Corporation
Cyberonics
BioControl Medical
Aleva Neurotherapeutics SA
Bioness
Uroplasty
Abbott Laboratories
St.Jude Medical
EnteroMedics
,Micron Medical Corporation
LivaNova PLC
NeuroPace
Synapse Biomedical
Soterix Medical
Accellent
Neuros Medical
Nevro Corp
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Internal Neuromodulation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Internal Neuromodulation Device, with price, sales, revenue and global market share of Internal Neuromodulation Device from 2018 to 2023.
Chapter 3, the Internal Neuromodulation Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Internal Neuromodulation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Internal Neuromodulation Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Internal Neuromodulation Device.
Chapter 14 and 15, to describe Internal Neuromodulation Device sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Internal Neuromodulation Device
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Internal Neuromodulation Device Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Metal Biomaterials
1.3.3 Polymer Biomaterial
1.3.4 Ceramic Biomaterial
1.4 Market Analysis by Application
1.4.1 Overview: Global Internal Neuromodulation Device Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Home Healthcare
1.4.5 Other
1.5 Global Internal Neuromodulation Device Market Size & Forecast
1.5.1 Global Internal Neuromodulation Device Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Internal Neuromodulation Device Sales Quantity (2018-2029)
1.5.3 Global Internal Neuromodulation Device Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic PLC
2.1.1 Medtronic PLC Details
2.1.2 Medtronic PLC Major Business
2.1.3 Medtronic PLC Internal Neuromodulation Device Product and Services
2.1.4 Medtronic PLC Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic PLC Recent Developments/Updates
2.2 BostonScientific Corporation
2.2.1 BostonScientific Corporation Details
2.2.2 BostonScientific Corporation Major Business
2.2.3 BostonScientific Corporation Internal Neuromodulation Device Product and Services
2.2.4 BostonScientific Corporation Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BostonScientific Corporation Recent Developments/Updates
2.3 Cyberonics
2.3.1 Cyberonics Details
2.3.2 Cyberonics Major Business
2.3.3 Cyberonics Internal Neuromodulation Device Product and Services
2.3.4 Cyberonics Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cyberonics Recent Developments/Updates
2.4 BioControl Medical
2.4.1 BioControl Medical Details
2.4.2 BioControl Medical Major Business
2.4.3 BioControl Medical Internal Neuromodulation Device Product and Services
2.4.4 BioControl Medical Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioControl Medical Recent Developments/Updates
2.5 Aleva Neurotherapeutics SA
2.5.1 Aleva Neurotherapeutics SA Details
2.5.2 Aleva Neurotherapeutics SA Major Business
2.5.3 Aleva Neurotherapeutics SA Internal Neuromodulation Device Product and Services
2.5.4 Aleva Neurotherapeutics SA Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aleva Neurotherapeutics SA Recent Developments/Updates
2.6 Bioness
2.6.1 Bioness Details
2.6.2 Bioness Major Business
2.6.3 Bioness Internal Neuromodulation Device Product and Services
2.6.4 Bioness Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bioness Recent Developments/Updates
2.7 Uroplasty
2.7.1 Uroplasty Details
2.7.2 Uroplasty Major Business
2.7.3 Uroplasty Internal Neuromodulation Device Product and Services
2.7.4 Uroplasty Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Uroplasty Recent Developments/Updates
2.8 Abbott Laboratories
2.8.1 Abbott Laboratories Details
2.8.2 Abbott Laboratories Major Business
2.8.3 Abbott Laboratories Internal Neuromodulation Device Product and Services
2.8.4 Abbott Laboratories Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abbott Laboratories Recent Developments/Updates
2.9 St.Jude Medical
2.9.1 St.Jude Medical Details
2.9.2 St.Jude Medical Major Business
2.9.3 St.Jude Medical Internal Neuromodulation Device Product and Services
2.9.4 St.Jude Medical Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 St.Jude Medical Recent Developments/Updates
2.10 EnteroMedics
2.10.1 EnteroMedics Details
2.10.2 EnteroMedics Major Business
2.10.3 EnteroMedics Internal Neuromodulation Device Product and Services
2.10.4 EnteroMedics Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 EnteroMedics Recent Developments/Updates
2.11 ,Micron Medical Corporation
2.11.1 ,Micron Medical Corporation Details
2.11.2 ,Micron Medical Corporation Major Business
2.11.3 ,Micron Medical Corporation Internal Neuromodulation Device Product and Services
2.11.4 ,Micron Medical Corporation Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ,Micron Medical Corporation Recent Developments/Updates
2.12 LivaNova PLC
2.12.1 LivaNova PLC Details
2.12.2 LivaNova PLC Major Business
2.12.3 LivaNova PLC Internal Neuromodulation Device Product and Services
2.12.4 LivaNova PLC Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 LivaNova PLC Recent Developments/Updates
2.13 NeuroPace
2.13.1 NeuroPace Details
2.13.2 NeuroPace Major Business
2.13.3 NeuroPace Internal Neuromodulation Device Product and Services
2.13.4 NeuroPace Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 NeuroPace Recent Developments/Updates
2.14 Synapse Biomedical
2.14.1 Synapse Biomedical Details
2.14.2 Synapse Biomedical Major Business
2.14.3 Synapse Biomedical Internal Neuromodulation Device Product and Services
2.14.4 Synapse Biomedical Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Synapse Biomedical Recent Developments/Updates
2.15 Soterix Medical
2.15.1 Soterix Medical Details
2.15.2 Soterix Medical Major Business
2.15.3 Soterix Medical Internal Neuromodulation Device Product and Services
2.15.4 Soterix Medical Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Soterix Medical Recent Developments/Updates
2.16 Accellent
2.16.1 Accellent Details
2.16.2 Accellent Major Business
2.16.3 Accellent Internal Neuromodulation Device Product and Services
2.16.4 Accellent Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Accellent Recent Developments/Updates
2.17 Neuros Medical
2.17.1 Neuros Medical Details
2.17.2 Neuros Medical Major Business
2.17.3 Neuros Medical Internal Neuromodulation Device Product and Services
2.17.4 Neuros Medical Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Neuros Medical Recent Developments/Updates
2.18 Nevro Corp
2.18.1 Nevro Corp Details
2.18.2 Nevro Corp Major Business
2.18.3 Nevro Corp Internal Neuromodulation Device Product and Services
2.18.4 Nevro Corp Internal Neuromodulation Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Nevro Corp Recent Developments/Updates
3 Competitive Environment: Internal Neuromodulation Device by Manufacturer
3.1 Global Internal Neuromodulation Device Sales Quantity by Manufacturer (2018-2023)
3.2 Global Internal Neuromodulation Device Revenue by Manufacturer (2018-2023)
3.3 Global Internal Neuromodulation Device Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Internal Neuromodulation Device by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Internal Neuromodulation Device Manufacturer Market Share in 2022
3.4.2 Top 6 Internal Neuromodulation Device Manufacturer Market Share in 2022
3.5 Internal Neuromodulation Device Market: Overall Company Footprint Analysis
3.5.1 Internal Neuromodulation Device Market: Region Footprint
3.5.2 Internal Neuromodulation Device Market: Company Product Type Footprint
3.5.3 Internal Neuromodulation Device Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Internal Neuromodulation Device Market Size by Region
4.1.1 Global Internal Neuromodulation Device Sales Quantity by Region (2018-2029)
4.1.2 Global Internal Neuromodulation Device Consumption Value by Region (2018-2029)
4.1.3 Global Internal Neuromodulation Device Average Price by Region (2018-2029)
4.2 North America Internal Neuromodulation Device Consumption Value (2018-2029)
4.3 Europe Internal Neuromodulation Device Consumption Value (2018-2029)
4.4 Asia-Pacific Internal Neuromodulation Device Consumption Value (2018-2029)
4.5 South America Internal Neuromodulation Device Consumption Value (2018-2029)
4.6 Middle East and Africa Internal Neuromodulation Device Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
5.2 Global Internal Neuromodulation Device Consumption Value by Type (2018-2029)
5.3 Global Internal Neuromodulation Device Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
6.2 Global Internal Neuromodulation Device Consumption Value by Application (2018-2029)
6.3 Global Internal Neuromodulation Device Average Price by Application (2018-2029)
7 North America
7.1 North America Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
7.2 North America Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
7.3 North America Internal Neuromodulation Device Market Size by Country
7.3.1 North America Internal Neuromodulation Device Sales Quantity by Country (2018-2029)
7.3.2 North America Internal Neuromodulation Device Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
8.2 Europe Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
8.3 Europe Internal Neuromodulation Device Market Size by Country
8.3.1 Europe Internal Neuromodulation Device Sales Quantity by Country (2018-2029)
8.3.2 Europe Internal Neuromodulation Device Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Internal Neuromodulation Device Market Size by Region
9.3.1 Asia-Pacific Internal Neuromodulation Device Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Internal Neuromodulation Device Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
10.2 South America Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
10.3 South America Internal Neuromodulation Device Market Size by Country
10.3.1 South America Internal Neuromodulation Device Sales Quantity by Country (2018-2029)
10.3.2 South America Internal Neuromodulation Device Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Internal Neuromodulation Device Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Internal Neuromodulation Device Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Internal Neuromodulation Device Market Size by Country
11.3.1 Middle East & Africa Internal Neuromodulation Device Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Internal Neuromodulation Device Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Internal Neuromodulation Device Market Drivers
12.2 Internal Neuromodulation Device Market Restraints
12.3 Internal Neuromodulation Device Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Internal Neuromodulation Device and Key Manufacturers
13.2 Manufacturing Costs Percentage of Internal Neuromodulation Device
13.3 Internal Neuromodulation Device Production Process
13.4 Internal Neuromodulation Device Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Internal Neuromodulation Device Typical Distributors
14.3 Internal Neuromodulation Device Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
• 日本語訳：体内神経調節装置の世界市場2023：金属生体材料、高分子生体材料、セラミックス生体材料
• レポートコード：MRC309Z7189 ▷ お問い合わせ（見積依頼・ご注文・質問）